Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission

JCI Insight(2023)10.1172/jci.insight.170671Source: DataRank Database

The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission is a research paper published in JCI Insight (2023). On theSindex it has a DataRank of 0. It has been cited 208 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access208 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 23.71)OA: goldTopics (32)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Mehdi Farokhnia ORCID,Sophia Khom ORCID,Claire Pince ORCID,Sophie K. Elvig ORCID,Roman Vlkolinský ORCID

Live enrichment

PubMed:37192005 OpenAlex:https://openalex.org/W4376643286

NIH

Grant: ZIA-DA-000635,ZIA-DA000602,ZIA-DA000644,AA029841,P60 AA006420,AA027700

FWCI

23.71

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://insight.jci.org/articles/view/170671/files/pdf

publisherhttp://insight.jci.org/articles/view/170671/files/pdf

publisherhttps://insight.jci.org/articles/view/170671/files/pdf

journalhttps://doi.org/10.1172/jci.insight.170671

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37192005

Fields of Study

Neuropeptides and Animal PhysiologyReceptor Mechanisms and SignalingNeurotransmitter Receptor Influence on Behavior

MeSH Terms

SemaglutideAlcohol DrinkingAlcoholismAnimalsFemalegamma-Aminobutyric AcidMaleSynaptic TransmissionMiceRatsGlucagon-Like Peptide 1

Keywords

SemaglutideAlcohol use disorderNeurotransmissionEndocrinologyAlcoholInternal medicineBinge drinkingChemistryPharmacologyMedicineNeurosciencePsychologyReceptorLiraglutideBiochemistryDiabetes mellitusAlcohol consumptionType 2 diabetes

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Response to semaglutide of non-drinker subjects with type 2 diabetes

10.6084/m9.figshare.25853087.v1figshare

Additional file 1 of Response to semaglutide of non-drinker subjects with type 2 diabetes

10.6084/m9.figshare.25853087figshare